European Union: EU Medical Device Regulation 2017/745 And In Vitro Diagnostic Regulation 2017/746

Following their adoption by the European Parliament in April 2017, the final versions of the Medical Devices Regulation ("MDR") and In Vitro Diagnostic Regulation ("IVDR") were published in the Official Journal of the European Union on May 5, 2017. The Regulations will enter into force on May 25, 2017, and will become fully applicable following a transitional period of three and five years, respectively. The MDR will apply as of May 26, 2020, and the IVDR will apply as of May 26, 2022. Both Regulations make some exceptions for early application as well as additional transitional periods.

These Regulations will replace the current Medical Devices Directive (93/42/EC on medical devices), the Active Implantable Medical Devices Directive (90/385/EC on active implantable medical devices ), and the In Vitro Diagnostics Directive (98/79/EC on in vitro diagnostic ("IVD") medical devices). The new Regulations are designed to improve the quality, safety, and reliability of medical devices and in vitro diagnostics; to strengthen transparency of consumer information; and to enhance vigilance and market surveillance while supporting innovation.

Summary of the Key Changes

Below is a high-level summary of some of the key changes brought by the MDR and IVDR to the regulatory framework applicable to medical devices.

Inclusion of Products Without Medical Purpose and New Classification Rules. Certain groups of products that do not have an intended medical purpose but that present a risk profile similar to medical devices have been included in the scope of the new MDR. Examples include contact lenses; facial, dermal, or mucous membrane filling substances or articles; and liposuction equipment and laser equipment for skin treatment. For IVDs, entirely new risk-based classification rules have been introduced by the IVDR. Beginning May 26, 2022, IVD medical devices will have to be categorized in classes A to D.

New Post-Market Clinical Requirements. As of the date of application of the new Regulations, medical device manufacturers will be required to include a post-market clinical follow-up or post-market performance follow-up (for IVDs) in their post-market surveillance system in order to continuously update the clinical evaluation of the device. For implantable and class III devices, a summary of safety and clinical performance must be drawn up by manufacturers and validated by notified bodies before being made publicly available.

Stricter Rules for Notified Bodies. All notified bodies will have to be redesignated under the MDR/IVDR and comply with all requirements laid down in the respective Annex VII of the new Regulations. Notified bodies must employ medically trained staff and, among other things, must have documented procedures regarding unannounced on-site audits of manufacturers and, where applicable, of subcontractors and suppliers. The MDR and IVDR also introduce a mechanism for scrutiny of certain high-risk medical devices. Under this procedure, a manufacturer's notified body will be required to notify the competent authorities of certificates it has granted for such high-risk devices. The competent authorities and, where applicable, the European Commission may request scientific advice from expert panels in relation to the safety and performance of any device, based on its reasonable concerns.

Introduction of the Unique Device Identification ("UDI") System. The new Regulations enhance traceability requirements of medical devices throughout the supply chain by requiring that a UDI be affixed to a medical device or to its packaging. Each component that is considered a device and is commercially available on its own will be assigned a separate UDI.

Joint Responsibility of Authorized Representatives. Non-EU manufacturers of medical devices and IVDs must appoint a European Authorized Representative in the European Union. Under the new Regulations, the European Authorized Representative will be responsible for verifying that the EU Declaration of Conformity and technical documentation have been drawn up by the manufacturer and, where applicable, that an appropriate conformity assessment procedure has been conducted. Most importantly, the European Authorized Representative would be legally liable, jointly and severally, with the manufacturer, for defective devices placed on the EU market if the medical devices are not compliant with the Regulations' requirements.

Increased Transparency. The UDI, along with post-market vigilance data and ongoing clinical investigations, must be entered into the European Databank on Medical Devices ("EUDAMED"), which will become accessible to the public. The EUDAMED database is expected to be put into place by 2020.

Transitional Provisions

The two Regulations include transitional provisions permitting CE Certificates of Conformity issued by notified bodies in accordance with the current Directives and prior to May 25, 2017, to remain valid until the end of the period indicated on the Certificates. Notified bodies will also be allowed to issue CE Certificates of Conformity in accordance with the current Directives after May 25, 2017. These Certificates will be issued for a period of validity not exceeding five years and will become void at the latest on May 27, 2024.

It should be noted that medical devices to which these Certificates relate may be placed on the EU market or put into service in the European Union only if, from May 26, 2020, or May 26, 2022, as the case may be, they remain in compliance with the relevant current Directives, and provided there are no significant changes in the design and intended purpose of the medical devices. Moreover, there will be related changes in some obligations related to the devices. The requirements of the MDR and IVDR relating to post-market surveillance, market surveillance, vigilance, and registration of economic operators and of devices will apply in place of the corresponding requirements in the Medical Device and In Vitro Diagnostic Directives.


Medical devices that comply with the MDR may be placed on the EU market before the MDR date of application (anticipated in May 2020) if they have been audited by a notified body designated under the MDR. Notified bodies can apply for redesignation from six months after the regulations take effect. They can test for compliance with the MDR requirements only once they have been redesignated. It has been reported that this process could take up to 18 months from the date of application for redesignation.

Therefore, in addition to monitoring the validity of their Certificates of Conformity, medical device manufacturers should ensure as soon as possible that their notified bodies will be redesignated or otherwise, initiate the process of contracting with a notified body that meets the new requirements of the new Regulations and will therefore be redesignated quickly.

In addition, the European Commission is set to adopt approximately 80 delegated and implementing acts to further specify applicable requirements and obligations under the new Regulations. Manufacturers of medical devices and in vitro diagnostics should monitor closely relevant developments.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Practice Guides
by Mondaq Advice Centers
Relevancy Powered by MondaqAI
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions